VSL#3 Probiotic Now Generally Recognized as Safe (Gras) for the Dietary Management of Irritable Bowel Syndrome (press release)

Thursday, October 12, 2006 by: NaturalNews
Tags: health news, Natural News, nutrition

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
BACK INTO THE CLOSET: Why U.S. reporters are not allowed to write about rainbow events in nations where being gay is still condemned
Depopulation test run? 75% of children who received vaccines in Mexican town now dead or hospitalized
A family destroyed: Six-month-old dies after clinic injects baby with 13 vaccines at once without mother's informed consent
INVESTIGATION: Three days before Dr. Bradstreet was found dead in a river, U.S. govt. agents raided his research facility to seize a breakthrough cancer treatment called GcMAF
BAM! Chipotle goes 100% non-GMO; flatly rejecting the biotech industry and its toxic food ingredients
BOMBSHELL: China and America already at war: Tianjin explosion carried out by Pentagon space weapon in retaliation for Yuan currency devaluation... Military helicopters now patrolling Beijing
ECONOMIC SLAVERY FOR ALL: While we were distracted with the Confederate flag flap, Congress quietly forfeited our entire economic future via fast-track trade authority
March Against Monsanto explodes globally... World citizens stage massive protests across 38 countries, 428 cities... mainstream media pretends it never happened
GMO crops totally banned in Russia... powerful nation blocks Monsanto's agricultural imperialism and mass poisoning of the population
SCOTUS same-sex marriage decision may have just legalized the concealed carry of loaded firearms across all 50 states, nullifying gun laws everywhere
Nearly every mass shooting in the last 20 years shares one surprising thing? and it's not guns
Vicious attack on Dr. Oz actually waged by biotech mafia; plot to destroy Oz launched after episode on glyphosate toxicity went viral
Holistic cancer treatment pioneer Dr. Nicholas Gonzalez dies suddenly; patients mourn the loss of a compassionate, innovative doctor who helped thousands heal from cancer
Pepsi drops aspartame from diet soda as consumers reject toxic sweetener
Bride of Frankenfood: Hillary Clinton pushes GMO agenda... hires Monsanto lobbyist... takes huge dollars from Monsanto
STATINS RED ALERT: Widely prescribed drugs act as cellular poisons that accelerate aging... deactivate DNA repair... promote diabetes, muscle fatigue and memory loss
Wild eyes and bowl cuts: Why do mass shooters always share the same hair styles and crazed zombie stares?
Mind control through emotional domination: How we're all being manipulated by the "crisis of the NOW"
New data has shown that VSL#3 provides effective relief in the dietary management of serious intestinal disorders such as ulcerative colitis and pouchitis. Based on recently published research from the Mayo Clinic, an independent panel of qualified experts has determined that VSL#3 is generally recognized as safe (GRAS), under the conditions of intended use as a medical food for the dietary management of irritable bowel syndrome (IBS). VSL#3 probiotic is a preparation of living microbial cells used extensively for the management of gastrointestinal disorders.

Probiotics, because of their potential to help manage GI distress symptoms, are the subject of widespread research. When ingested, probiotics positively influence the composition of the bacterial population in the intestines. Normally, intestinal bacteria act as a protective barrier in the gastrointestinal (GI) tract, but in some situations, the ‘bad’ bacteria outnumber the ‘good’ bacteria. IBS is characterized by abdominal pain or discomfort due to gas (flatulence) and bloating that is associated with a change in bowel pattern (loose or more frequent bowel movements, diarrhea and/or constipation, etc).

“There is evidence that probiotics such as VSL#3 have a role in the management of inflammatory intestinal disorders such as pouchitis, and increasing evidence that they may alleviate some of the symptoms associated with IBS,” said Jay W. Marks, M.D. a board certified internist and gastroenterologist from UCLA/Cedars-Sinai Medical Center. “Recent studies have demonstrated that probiotics, including VSL#3, are safe and have a promising therapeutic benefit for IBS patients.”

VSL#3 works by colonizing the GI tract with probiotic bacteria that adhere to the walls and form a barrier that protects the inner layer of the gut from “bad” bacteria and other substances that cause inflammation. Results of previous research suggest immune function, motility and the intestinal environment are positively influenced by probiotics.

One study looked at the effect of individual bacteria on IBS symptoms, and found probiotics contributed to the production of anti-inflammatory agents, thus reducing inflammation. In addition, probiotic bacteria may also provide relief for patients with functional diarrhea, or IBS with diarrhea, by altering the intestinal environment. Bloated IBS patients (with and without diarrhea) reported experiencing significantly improved bowel control with VSL#3 relative to placebo. Research suggests certain bacteria may influence the secretion of fluids in the colon that contribute to functional diarrhea or IBS with diarrhea. Among all studies, no serious side effects were reported.

According to Dr. Marks, “Patients and their physicians should be aware of the potential of probiotics such as VSL#3 to manage pouchitis and some symptoms of IBS.”

GRAS is an FDA designation that acknowledges certain food additives as safe under the conditions of their intended use by qualified experts. To receive such recognition, the product must establish a consensus of expert opinion regarding the safety of its use based on a review of scientific evidence.

About Sigma-Tau Pharmaceuticals, Inc.

Working to Make Rare Diseases Even Rarer There are some 6,000 identified rare diseases that affect approximately 10 million patients in the United States. The founding principle and core belief of Sigma-Tau Pharmaceuticals, Inc., a wholly owned U.S. subsidiary of Sigma-Tau S.p.A., is that finding therapies for rare diseases is just as important as finding ones for more common diseases. After all, to the patient, there’s nothing “rare” about their condition.

To that end, Sigma-Tau Pharmaceuticals has been focused on rare diseases since its founding, and was one of the first companies to obtain an Orphan Drug Designation in the United State more than 20 years ago.

The Sigma-Tau group is always looking to explore entirely new approaches to treating disease. This is illustrated by the company’s study of the biologic underlying diseases, an alternative approach referred to as “biologic pharmacology.” The research is based on the assumption that disease begins at the metabolic level, when the biochemical pathways within cells and communication among them are altered.

Source: Chamberlain Communications Group

Follow real-time breaking news headlines on
Health news at
Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...


Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of, the internet's No. 1 natural health news site. (Source:

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.